C
TBPH icon

Chescapmanager’s Theravance Biopharma TBPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-96,197
Closed -$816K 30
2024
Q2
$816K Sell
96,197
-105,168
-52% -$892K 0.07% 26
2024
Q1
$1.81M Sell
201,365
-28,403
-12% -$255K 0.18% 27
2023
Q4
$2.58M Sell
229,768
-57,565
-20% -$647K 0.25% 21
2023
Q3
$2.48M Hold
287,333
0.32% 24
2023
Q2
$2.97M Sell
287,333
-335,405
-54% -$3.47M 0.46% 25
2023
Q1
$6.76M Sell
622,738
-228,250
-27% -$2.48M 1.06% 19
2022
Q4
$9.55M Sell
850,988
-309,515
-27% -$3.47M 2.24% 14
2022
Q3
$11.8M Hold
1,160,503
2.74% 11
2022
Q2
$10.5M Sell
1,160,503
-6,071
-0.5% -$55K 2.48% 12
2022
Q1
$11.2M Sell
1,166,574
-95,100
-8% -$909K 1.51% 18
2021
Q4
$13.9M Sell
1,261,674
-630,778
-33% -$6.97M 1.86% 22
2021
Q3
$14M Buy
1,892,452
+630,734
+50% +$4.67M 1.98% 19
2021
Q2
$18.3M Buy
1,261,718
+127,000
+11% +$1.84M 2.01% 14
2021
Q1
$23.2M Hold
1,134,718
2.47% 9
2020
Q4
$20.2M Sell
1,134,718
-23,000
-2% -$409K 2.46% 10
2020
Q3
$17.1M Buy
1,157,718
+60,000
+5% +$887K 2.77% 12
2020
Q2
$23M Buy
1,097,718
+95,000
+9% +$1.99M 3.88% 6
2020
Q1
$23.2M Buy
1,002,718
+53,712
+6% +$1.24M 5.67% 5
2019
Q4
$24.6M Buy
949,006
+351,422
+59% +$9.1M 3.61% 7
2019
Q3
$11.6M Buy
597,584
+48,835
+9% +$951K 1.66% 15
2019
Q2
$8.96M Buy
548,749
+99,885
+22% +$1.63M 0.89% 19
2019
Q1
$10.2M Buy
448,864
+33,943
+8% +$770K 1.21% 17
2018
Q4
$10.6M Buy
414,921
+6,000
+1% +$154K 2.56% 16
2018
Q3
$13.4M Buy
408,921
+5,600
+1% +$183K 1.37% 21
2018
Q2
$9.15M Buy
403,321
+52,690
+15% +$1.19M 1.06% 24
2018
Q1
$8.5M Buy
350,631
+57,614
+20% +$1.4M 1.27% 24
2017
Q4
$8.17M Buy
293,017
+11,480
+4% +$320K 1.33% 22
2017
Q3
$9.64M Buy
281,537
+60,420
+27% +$2.07M 1.88% 19
2017
Q2
$8.81M Buy
221,117
+1,814
+0.8% +$72.3K 1.49% 19
2017
Q1
$8.08K Sell
219,303
-52,850
-19% -$1.95K 1.11% 21
2016
Q4
$8.68M Buy
+272,153
New +$8.68M 3.18% 12